Abstract
Engagement of the Granulocyte-Colony-Stimulating Factor (G-CSF) receptor activates non-receptor protein tyrosine kinases Lyn and Jak2. We found that Lyn-deficient DT40 cells that express the G-CSF receptor (DT40GR) do not demonstrate G-CSF-induced mitogenic signaling. Lyn associates with and phosphorylates a small set of molecules, including c-Cbl. c-Cbl is an adaptor involved in cell growth and cytoskeletal reorganization, predominantly in hematopoietic cells. Using yeast two-hybrid analysis, we found that c-Cbl directly couples Lyn to PI 3-kinase. We also found that expression of the c-CblY731F mutant, which uncouples PI 3-kinase, resulted in the inhibition of G-CSF-induced proliferative signaling in DT40GR cells. As a complementary strategy, we sought to analyse the effects of c-Cbl deficiency in DT40GR cells. We isolated, cloned and sequenced the full-length cDNA for chicken c-Cbl and constructed antisense vectors. Antisense inhibition of c-Cbl expression in DT40GR cells led to enhanced Jak-STAT activation following G-CSF stimulation. Yet, this enhancement of Jak-STAT activation was associated with decreased G-CSF-induced PI 3-kinase activity and DNA synthesis. PI 3-kinase activity correlated with DNA synthesis and physiological levels of c-Cbl. Together, these data suggest that physiologic level of c-Cbl provides a growth stimulatory pathway for G-CSF and that enhanced Jak-STAT activation is not sufficient for G-CSF-induced growth.
Similar content being viewed by others
References
Andoniou CE, Lill NL, Thien CB, Lupher Jr ML, Ota S, Bowtell DD, Scaife RM, Langdon WY, Band H . 2000 Mol. Cell. Biol. 20: 851–867
Arron JR, Vologodskaia M, Wong BR, Naramura M, Kim N, Gu H, Choi Y . 2001 J. Biol. Chem. 276: 30011–30017
Avalos BR . 1996 Blood 88: 761–777
Bachmaier K, Krawczyk C, Kozieradzki I, Kong YY, Sasaki T, Oliveira-dos-Santos A, Mariathasan S, Bouchard D, Wakeham A, Itie A, Le J, Ohashi PS, Sarosi I, Nishina H, Lipkowitz S, Penninger JM . 2000 Nature 403: 211–216
Chiang YJ, Kole HK, Brown K, Naramura M, Fukuhara S, Hu RJ, Jang IK, Gutkind JS, Shevach E, Gu H . 2000 Nature 403: 216–220
Corey SJ, Burkhardt AL, Bolen JB, Geahlen RL, Tkatch LS, Tweardy DJ . 1994 Proc. Natl. Acad. Sci. USA 91: 4683–4687
Corey SJ, Dombrosky-Ferlan PM, Zuo S, Krohn E, Donnenberg AD, Zorich P, Romero G, Takata M, Kurosaki T . 1998 J. Biol. Chem. 273: 3230–3235
de Jong R, ten Hoeve J, Heisterkamp N, Groffen J . 1995 J. Biol. Chem. 270: 21468–21471
Dombrosky-Ferlan PM, Corey SJ . 1997 Oncogene 14: 2019–2024
Elly C, Witte S, Zhang Z, Rosnet O, Lipkowitz S, Altman A, Liu YC . 1999 Oncogene 18: 1147–1156
Erdreich-Epstein A, Liu M, Kant AM, Izadi KD, Nolta JA, Durden DL . 1999 J. Leukoc. Biol. 65: 523–534
Ettenberg SA, Keane MM, Nau MM, Frankel M, Wang LM, Pierce JH, Lipkowitz S . 1999 Oncogene 18: 1855–1866
Fang D, Wang HY, Fang N, Altman Y, Elly C, Liu YC . 2001 J. Biol. Chem. 276: 4872–4878
Felsenstein J . 1995 PHYLIP (Phylogeny Inference Package) Seattle: University of Washington
Finkelstein LD, Shimizu Y . 2000 Biochem. J. 345: Pt 2 385–392
Garcia-Guzman M, Larsen E, Vuori K . 2000 Oncogene 19: 4058–4065
Grishin A, Sinha S, Roginskaya V, Boyer MJ, Gomez-Cambronero J, Zuo S, Kurosaki T, Romero G, Corey SJ . 2000 Oncogene 19: 97–105
Hamilton E, Miller KM, Helm KM, Langdon WY, Anderson SM . 2001 J. Biol. Chem. 276: 9028–9037
Hartley D, Meisner H, Corvera S . 1995 J. Biol. Chem. 270: 18260–18263
Hsueh RC, Scheuermann RH . 2000 Adv. Immunol. 75: 283–316
Ikeda M, Ikeda A, Longan LC, Longnecker R . 2000 Virology 268: 178–191
Joazeiro CA, Wing SS, Huang H, Leverson JD, Hunter T, Liu YC . 1999 Science 286: 309–312
Kawakami Y, Kitaura J, Satterthwaite AB, Kato RM, Asai K, Hartman SE, Maeda-Yamamoto M, Lowell CA, Rawlings DJ, Witte ON, Kawakami T . 2000 J. Immunol. 165: 1210–1219
Keane MM, Ettenberg SA, Nau MM, Banerjee P, Cuello M, Penninger J, Lipkowitz S . 1999 Oncogene 18: 3365–3375
Keane MM, Rivero-Lezcano OM, Mitchell JA, Robbins KC, Lipkowitz S . 1995 Oncogene 10: 2367–2377
Kim M, Tezuka T, Suziki Y, Sugano S, Hirai M, Yamamoto T . 1999 Gene 239: 145–154
Lahti JM . 1999 Methods 17: 305–312
Langdon WY, Hartley JW, Klinken SP, Ruscetti SK, Morse HCd . 1989 Proc. Natl. Acad. Sci. USA 86: 1168–1172
Liu YC, Altman A . 1998 Cell Signal 10: 377–385
Lupher Jr ML, Rao N, Eck MJ, Band H . 1999 Immunol. Today 20: 375–382
Meng F, Lowell CA . 1998 EMBO J. 17: 4391–4403
Murphy MA, Schnall RG, Venter DJ, Barnett L, Bertoncello I, Thien CB, Langdon WY, Bowtell DD . 1998 Mol. Cell. Biol. 18: 4872–4882
Naramura M, Kole HK, Hu RJ, Gu H . 1998 Proc. Natl. Acad. Sci. USA 95: 15547–15552
Neubauer H, Cumano A, Muller M, Wu H, Huffstadt U, Pfeffer K . 1998 Cell 93: 397–409
Nishizumi H, Horikawa K, Mlinaric-Rascan I, Yamamoto T . 1998 J. Exp. Med. 187: 1343–1348
Nishizumi H, Taniuchi I, Yamanashi Y, Kitamura D, Ilic D, Mori S, Watanabe T, Yamamoto T . 1995 Immunity 3: 549–560
Oda H, Kumar S, Howley PM . 1999 Proc. Natl. Acad. Sci. USA 96: 9557–9562
Parganas E, Wang D, Stravopodis D, Topham DJ, Marine JC, Teglund S, Vanin EF, Bodner S, Colamonici OR, van Deursen JM, Grosveld G, Ihle JN . 1998 Cell 93: 385–395
Rao N, Miyake S, Reddi AL, Douillard P, Ghosh AK, Dodge IL, Zhou P, Fernandes ND, Band H . 2002 Proc. Natl. Acad. Sci. USA 99: 3794–3799
Rodig SJ, Meraz MA, White JM, Lampe PA, Riley JK, Arthur CD, King KL, Sheehan KC, Yin L, Pennica D, Johnson Jr EM, Schreiber RD . 1998 Cell 93: 373–383
Saci A, Rendu F, Bachelot-Loza C . 2000 Biochem. J. 351: Pt 3 669–676
Satterthwaite AB, Lowell CA, Khan WN, Sideras P, Alt FW, Witte ON . 1998 J. Exp. Med. 188: 833–844
Sattler M, Salgia R, Shrikhande G, Verma S, Pisick E, Prasad KV, Griffin JD . 1997 J. Biol. Chem. 272: 10248–10253
Scholz G, Cartledge K, Dunn AR . 2000 J. Biol. Chem. 275: 14615–14623
Sinha S, Jancarik J, Roginskaya V, Rothermund K, Boxer LM, Corey SJ . 2001 Exp. Hematol. 29: 746–755
Takata M, Sabe H, Hata A, Inazu T, Homma Y, Nukada T, Yamamura H, Kurosaki T . 1994 EMBO J. 13: 1341–1349
Tezuka T, Umemori H, Fusaki N, Yagi T, Takata M, Kurosaki T, Yamamoto T . 1996 J. Exp. Med. 183: 675–680
Thien CB, Walker F, Langdon WY . 2001 Mol. Cell 7: 355–365
Thompson JD, Higgins DG, Gibson TJ . 1994 Nucleic Acids Res. 22: 4673–4680
Ueno H, Sasaki K, Honda H, Nakamoto T, Yamagata T, Miyagawa K, Mitani K, Yazaki Y, Hirai H . 1998 Blood 91: 46–53
Ueno H, Sasaki K, Miyagawa K, Honda H, Mitani K, Yazaki Y, Hirai H . 1997 J. Biol. Chem. 272: 8739–8743
Willeke T, Behrens S, Scharffetter-Kochanek K, Gaehtgens P, Walzog B . 2000 J. Leukoc. Biol. 68: 284–292
Yasuda T, Maeda A, Kurosaki M, Tezuka T, Hironaka K, Yamamoto T, Kurosaki T . 2000 J. Exp. Med. 191: 641–650
Yokouchi M, Kondo T, Sanjay A, Houghton A, Yoshimura A, Komiya S, Zhang H, Baron R . 2001 J. Biol. Chem. 276: 35185–35193
Zheng N, Wang P, Jeffrey PD, Pavletich NP . 2000 Cell 102: 533–539
Author information
Authors and Affiliations
Corresponding author
Additional information
The full-length nucleotide sequence of the chicken c-Cbl cDNA has been registered as GenBank accession number AF318895.
Rights and permissions
About this article
Cite this article
Wang, L., Rudert, W., Loutaev, I. et al. Repression of c-Cbl leads to enhanced G-CSF Jak-STAT signaling without increased cell proliferation. Oncogene 21, 5346–5355 (2002). https://doi.org/10.1038/sj.onc.1205670
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205670
- Springer Nature Limited
Keywords
This article is cited by
-
Overexpression of E3 ubiquitin ligase Cbl attenuates endothelial dysfunction in diabetes mellitus by inhibiting the JAK2/STAT4 signaling and Runx3-mediated H3K4me3
Journal of Translational Medicine (2021)
-
B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src/STAT3 and c-Cbl-mediated degradation of SOCS3
Leukemia (2019)
-
Time resolved quantitative phospho-tyrosine analysis reveals Bruton’s Tyrosine kinase mediated signaling downstream of the mutated granulocyte-colony stimulating factor receptors
Leukemia (2019)